| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.43 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |